| MM | macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle... |
|---|---|
| SMCD | senile macular choroidal degeneration; systemic mast cell disease; systemic meningococcal disease |
| MD | Meningococcal Disease |
|---|---|
| MCD | Meningococcal disease |
| acute fulminating meningococcal septicaemia | <radiology> Septicaemia (e.g., meningococcaemia), haemorrhagic necrosis of adrenals due to, septic emboli, disseminated intravascular coagulopathy (DIC), most likely to be adrenal haemorrhage and/or calcification (12 Dec 1998) |
|---|---|
| meningitis, meningococcal | Inflammation in response to infection with neisseria meningitidis of the pia-arachnoid and the fluid residing in the space which it encloses as well as the fluid in the ventricles of the brain. This condition occurs most often in children and adolescents. (12 Dec 1998) |
| meningococcal infections | Infections with bacteria of the species neisseria meningitidis. (12 Dec 1998) |
| meningococcal meningitis | An acute infectious disease affecting children and young adults, caused by Neisseria meningitidis; characterised by nasopharyngeal catarrh, headache, vomiting, convulsions, stiffness in the neck (nuchal rigidity), photophobia, constipation, cutaneous hyperesthesia, a purpuric or herpetic eruption, and the presence of Kernig's sign. Fulminant form may cause Waterhouse-Friderichsen syndrome. Synonym: cerebrospinal fever, epidemic cerebrospinal meningitis. (05 Mar 2000) |
| aids vaccines | Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent aids. Some vaccines containing antigens are recombinantly produced. (12 Dec 1998) |
| bacterial vaccines | Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. (12 Dec 1998) |
| cancer vaccines | Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumour cells as the source of antigens, or using tumour-specific antigens, often recombinantly produced. (12 Dec 1998) |
| vaccines | Vaccines are microbial preparations of killed or modified microorganisms which can stimulate an immune response in the body in order to prevent future infection with similar microorganism. The smallpox vaccine has totally eliminated the smallpox disease from our planet. (12 Dec 1998) |
| vaccines, attenuated | Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| vaccines, conjugate | Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. (12 Dec 1998) |
| vaccines, DNA | Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers. (12 Dec 1998) |
| vaccines, inactivated | Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. (12 Dec 1998) |
| vaccines, synthetic | Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. (12 Dec 1998) |
| malaria vaccines | Vaccines made from antigens arising from any of the four strains of plasmodium which cause malaria in humans, or from p. Berghei which causes malaria in rodents. (12 Dec 1998) |
Synonyms : Bivalent Meningococcal Vaccine, Meningococcal Polysaccharide Vaccine, Meningococcal Vaccine, Menomune, Tetravalent Meningococcal Vaccine, Meningococcal Vaccine, Bivalent, Meningococcal Vaccine, Tetravalent, Polysaccharide Vaccine, Meningococcal
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|